BME

BlackRock Health Sciences Trust (the Trust) is a closed-end management investment company. The Trust investment objective is to provide total return through a combination of current income and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, approximately 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives with exposure to the health sciences industry. The Trust is focused on achieving its goal primarily by investing in a portfolio of equity securities and also by employing a strategy of writing (selling) call and put options. The Trust invests in a portfolio of sectors, which include biotechnology, health care equipment and supplies, life sciences tools and services, and pharmaceuticals. BlackRock Advisors, LLC acts as the manager of the Trust.

Wall Street analysts forecast BME stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for BME is  USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Blackrock Health Sciences Trust revenue for the last quarter amounts to NaN USD, decreased % YoY.

Blackrock Health Sciences Trust. EPS for the last quarter amounts to USD, decreased % YoY.

Blackrock Health Sciences Trust (BME) has 0 emplpoyees as of December 19 2025.

Today BME has the market capitalization of 0.00 USD.